Placing the RPL32 Promoter Upstream of a Second Promoter Results in a Strongly Increased Number of Stably Transfected Mammalian Cell Lines That Display High Protein Expression Leve...

Por Hoeksema, F., Hamer, K., Siep, M., Verhees, J. A., Otte, A. P.
Publicado em 2010

Exploring the phase diagram of the two-impurity Kondo problem

Por Spinelli, A., Gerrits, M., Toskovic, R., Bryant, B., Ternes, M., Otte, A. F.
Publicado no Nat Commun (2015)

Methods to create a stringent selection system for mammalian cell lines

Por Van Blokland, H. J. M., Hoeksema, F., Siep, M., Otte, A. P., Verhees, J. A.
Publicado em 2011

Adaptive Mutations That Occurred during Circulation in Humans of H1N1 Influenza Virus in the 2009 Pandemic Enhance Virulence in Mice

Por Otte, A., Sauter, M., Daxer, M. A., McHardy, A. C., Klingel, K., Gabriel, G.
Publicado no J Virol (2015)

Influence of spinal cord injury on cerebral sensorimotor systems: a PET study.

Por Roelcke, U, Curt, A, Otte, A, Missimer, J, Maguire, R P, Dietz, V, Leenders, K L
Publicado em 1997

The Wnt-1 (int-1) oncogene promoter and its mechanism of activation by insertion of proviral DNA of the mouse mammary tumor virus.

Por Nusse, R, Theunissen, H, Wagenaar, E, Rijsewijk, F, Gennissen, A, Otte, A, Schuuring, E, van Ooyen, A
Publicado em 1990

PET and SPECT in whiplash syndrome: a new approach to a forgotten brain?

Por Otte, A, Ettlin, T, Nitzsche, E, Wachter, K, Hoegerle, S, Simon, G, Fierz, L, Moser, E, Mueller-Brand, J
Publicado em 1997

Ring1A is a transcriptional repressor that interacts with the Polycomb-M33 protein and is expressed at rhombomere boundaries in the mouse hindbrain.

Por Schoorlemmer, J, Marcos-Gutiérrez, C, Were, F, Martínez, R, García, E, Satijn, D P, Otte, A P, Vidal, M
Publicado em 1997

Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET

Por Weiner, S, Otte, A, Schumacher, M, Klein, R, Gutfleisch, J, Brink, I, Otto, P, Nitzsche, E, Moser, E, Peter, H
Publicado em 2000

Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma

Por Engelsen, I B, Mannelqvist, M, Stefansson, I M, Carter, S L, Beroukhim, R, Øyan, A M, Otte, A P, Kalland, K H, Akslen, L A, Salvesen, H B
Publicado em 2008

Identification and characterization of interactions between the vertebrate polycomb-group protein BMI1 and human homologs of polyhomeotic.

Por Gunster, M J, Satijn, D P, Hamer, K M, den Blaauwen, J L, de Bruijn, D, Alkema, M J, van Lohuizen, M, van Driel, R, Otte, A P
Publicado em 1997

Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis

Por Fluge, Ø, Gravdal, K, Carlsen, E, Vonen, B, Kjellevold, K, Refsum, S, Lilleng, R, Eide, T J, Halvorsen, T B, Tveit, K M, Otte, A P, Akslen, L A, Dahl, O
Publicado em 2009

RING1 is associated with the polycomb group protein complex and acts as a transcriptional repressor.

Por Satijn, D P, Gunster, M J, van der Vlag, J, Hamer, K M, Schul, W, Alkema, M J, Saurin, A J, Freemont, P S, van Driel, R, Otte, A P
Publicado em 1997

Interference with the expression of a novel human polycomb protein, hPc2, results in cellular transformation and apoptosis.

Por Satijn, D P, Olson, D J, van der Vlag, J, Hamer, K M, Lambrechts, C, Masselink, H, Gunster, M J, Sewalt, R G, van Driel, R, Otte, A P
Publicado em 1997